Novel PNLIPRP3 and DOCK8 gene expression and prognostic implications of DNA loss on chromosome 10q25.3 in hepatocellular carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 3, 2009, Pages 501-506

  Saelee, Pensri ^a   Wongkham, Sopit ^b   Puapairoj, Anucha ^b   Khuntikeo, Narong ^b   Petmitr, Songsak ^c   Chariyalertsak, Sunanta ^a   Sumethchotimaytha, Wutthi ^a   Karalak, Anant ^a  

^a NATIONAL CANCER INSTITUTE   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

10q25.3; AP PCR; Genetic alterations; HCC; Prognostic factor

Indexed keywords

EID: 77951161588     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Achille A, Biasi MO, Zamboni G, et al (1996). Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res, 56, 3808-13.
2. Buendia MA (2000). Genetics of hepatocellular carcinoma. Semin Cancer Biol, 10, 185-200.
3. Chariyalertsak S, Khuhaprema T, Bhudisawasdi V, et al (2005). Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction. J Cancer Res Clin Oncol, 131, 821-8.
4. Chu LW, Troncoso P, Johnston DA, et al (2003). Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer. Genes Chromosomes Cancer, 36, 303-12.
5. Chuensumran U, Wongkham S, Pairojkul C, et al (2007). Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma. World J Gastroenterol, 13, 2986-91.
6. de La Coste A, Romagnolo B, Billuart P, et al (1998). Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA, 95, 8847-51.
7. De Souza AT, Hankins GR, Washington MK, et al (1995). Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene, 10, 1725-9.
8. Edmonson HA, Steiner PE (1954). Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer, 7, 462-503.
9. Elmileik H, Paterson AC, Kew MC, et al (2005). Beta-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation, and hepatitis B virus infection in southern African Blacks with hepatocellular carcinoma. J Surg Oncol, 91, 258-63.
10. Fujiwara Y, Hoon DS, Yamada T, et al (2000). PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas. Jpn J Cancer Res, 91, 287-92.
11. Fukai K, Yokosuka O, Imazeki F, et al (2005). Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma. Liver Int, 25, 1209-16.
12. Hsu LS, Lee HC, Chau GY, et al (2006). Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep, 15, 507-11.
13. Idbaih A, Carvalho Silva R, Crinière E, et al (2008). Genomic changes in progression of low-grade gliomas. J Neurooncol, 90, 133-40.
14. Kawakami K, Yasuda J, Shiraishi M, et al (1998). Detection of DNA abnormalities by arbitrarily primed PCR fingerprinting: allelic losses in chromosome 10q in lung cancers. Biochem Biophys Res Commun, 251, 153-7.
15. Khuhaprema T, Srivatanakul P, Sriplung H, et al (2007). Cancer in Thailand Vol. IV, 1998-2000. Bnagkok Medical Publisher, Thailand, p.36.
16. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-8.
17. Marchio A, Meddeb M, Pineau P, et al (1997). Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer, 18, 59-65.
18. Miller SA, Dykes DD, Polesky HF, (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215.
19. Nishida N, Fukuda Y, Kokuryu H, et al (1993). Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res, 53, 368-72.
20. Nishida N, Fukuda Y, Komeda T, et al (1994). Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res, 54, 3107-10.
21. Pakeetoot T, Punyarit P, Petmitr S, (2007). Novel DNA amplification on chromosome 6q23-24 and 4p15.2 in breast cancer identified by arbitrarily primed polymerase chain reaction. J Exp Clin Cancer Res, 26, 253-9.
22. Peiffer SL, Herzog TJ, Tribune DJ, et al (1995). Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res, 55, 1922-6.
23. Peinado MA, Malkhosyan S, Velazquez A, et al (1992). Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc Natl Acad Sci USA, 89, 10065-9.
24. Piao Z, Park C, Park JH, et al (1998). Allelotype analysis of hepatocellular carcinoma. Int J Cancer, 75, 29-33.
25. Pongstaporn W, Rochanawutanon M, Wilailak S, et al (2006). Genetic alterations in chromosome 10q24.3 and glutathione S-transferase Omega 2 gene polymorphism in ovarian cancer. J Exp Clin Cancer Res, 25, 107-14.
26. Rossi MR, Conroy J, McQuaid D, et al (2006). Array CGH analysis of pediatric medulloblastomas. Genes Chromosomes Cancer, 45, 290-303.
27. Saelee P, Wongkham S, Bhudhisawasdi V, et al (2008). Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol, 134, 1135-41.
28. Singh KP, Roy D (2001). Identification of novel breast tumorspecific mutation(s) in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting. Gene, 269, 33-43.
29. Takahashi K, Kohno T, Ajima R, et al (2006). Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. Int J Oncol, 28, 321-8.
30. Welsh J, McClelland M (1990). Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res, 18, 7213-8.
31. Welsh J, Rampino N, McClelland M, et al (1995). Nucleic acid fingerprinting by PCR-based methods: applications to problems in aging and mutagenesis. Mutat Res, 338, 215-29.
32. Xian ZH, Cong WM, Zhang SH, et al (2005). Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment. World J Gastroenterol, 11, 4102-7.
33. Yakicier MC, Irmak MB, Romano A, et al (1999). Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene, 18, 4879-83.
34. Zhang X, Xu HJ, Murakami Y, et al (1994). Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res, 54, 4177-82.
35. Zhu GN, Zuo L, Zhou Q, et al (2004). Loss of heterozygosity on chromosome 10q22-10q23 and 22q11.2-22q12.1 and p53 gene in primary hepatocellular carcinoma. World J Gastroenterol, 10, 1975-8.